MedTrace Logo

Trial of Repeated Analgesia With Kangaroo Care - 18 Month Follow-up

NCT02694692 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2017-03-08

No results posted yet for this study

Summary

The primary aim for this study is to determine if maternal Kangaroo Care (KC) provided during painful procedures in early life will mitigate stress release and will improve neurobehavioural outcomes in infants, decrease subsequent pain response, and enhance maternal-child interaction beyond the period of hospitalization.

Conditions

Interventions

PROCEDURE

Vaccinations at 2, 6, 12 and 18 month

Participants will be invited back to IWK Health Centre at time points that correspond to their 2, 6, 12 and 18 month vaccinations and will receive their vaccinations according to Nova Scotia schedule.

BEHAVIORAL

Neurodevelopment assessment at 18 corrected age

During the 18 month follow-up visit, the infants will also undergo neurodevelopmental assessment. Trained medical assessors also blind to original study group assignment will examine the child using the BSID-III Cognitive and Motor Sections. Participants will also be contacted at the infants 18 month corrected postnatal age for the BSIDIII. Parents will be asked to complete the Early Childhood Behaviour Questionnaire and the Brief Infant Toddler Social Emotional Assessment.

Sponsors & Collaborators

  • Nova Scotia Health Research Foundation

    collaborator OTHER_GOV

  • IWK Health Centre

    lead OTHER

Principal Investigators

  • Marsha Campbell-Yeo, RN, NNP, PhD · IWK Health Centre

Eligibility

Min Age
2 Months
Max Age
20 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02694692 on ClinicalTrials.gov